South Rampart Pharma

South Rampart Pharma aims to advance the safe treatment of pain by developing new small-molecule solutions that have the potential to overcome many of the risks associated with current analgesics. The lead compounds from South Rampart Pharma effectively alleviated pain and fever in preclinical studies without the hepato-renal toxicity associated with current non-opioid analgesics. As a novel small-molecule therapeutic option that is non-biologic, South Rampart Pharma's compounds hold significant potential as a low-cost, high-value product accessible to many patients.